<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorder of connective tissue</z:e> caused by mutations in the fibrillin 1 gene (FBN1) </plain></SENT>
<SENT sid="1" pm="."><plain>FBN1 mutations have been associated with a broad spectrum of phenotypes </plain></SENT>
<SENT sid="2" pm="."><plain>Neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> has unique clinical manifestations and mutations </plain></SENT>
<SENT sid="3" pm="."><plain>OBJECTIVE: To determine if there is a discernible genotypic-phenotypic correlation associated with the unique mutation in neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>STUDY DESIGN: A newborn exhibited many typical characteristics of neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, including <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo>; <z:hpo ids='HP_0001371'>contractures</z:hpo> of both elbows, knees, and ankles; small-<z:hpo ids='HP_0001388'>joint laxity</z:hpo>; <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo>; valvular <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and insufficiency; <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>; and <z:hpo ids='HP_0002097'>pulmonary emphysema</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Three atypical features were also discovered: a right <z:hpo ids='HP_0000776'>diaphragmatic hernia</z:hpo>, a myocardial mass, and left main-stem <z:hpo ids='HP_0002780'>bronchomalacia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>She died at 3(1/2) months of age </plain></SENT>
<SENT sid="7" pm="."><plain>Total <z:chebi fb="40" ids="33697">RNA</z:chebi> was extracted from skin fibroblasts and amplified by means of reverse transcriptase polymerase chain reaction amplification with FBN1-specific primers </plain></SENT>
<SENT sid="8" pm="."><plain>The complementary DNA fragments were sequenced </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: A single T-to-C transition at nucleotide 3276 (T3276C) was identified and confirmed at the DNA level by sequencing of genomic DNA </plain></SENT>
<SENT sid="10" pm="."><plain>This results in a substitution of threonine for isoleucine </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is a unique clinical entity with recurring mutation hot spots in exons 24 to 27 and 31 to 32 of the FBN1 gene </plain></SENT>
<SENT sid="12" pm="."><plain>Some clinical features in this case report are unusual for neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>This is the third report of this T3276C mutation in the FBN1 gene with unusual clinical manifestations </plain></SENT>
<SENT sid="14" pm="."><plain>We conclude that there is a genotypic-phenotypic correlation associated with this mutation </plain></SENT>
</text></document>